TURTLE CAMERON (Chief Business Officer) sold 20.5% of their position (13.41K shares) of EIDOS THERAPEUTICS, INC. on the open market
Open‑market sale worth $999.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 11/13/2020ACC: 0000899243-20-031006
Officer· Chief Business Officer
Since Nov 2018
-14.91K
Net shares
Net seller
$999.2K
Total sold
3
Open market trades
0B · 3S
4
Total transactions
14.91K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−3K
Price / share
$73.56
Trade value
$221.06K
% of position
4.6%
11/11/2020
65.53K→62.53K
Common Stock
Direct
Shares
−9.50K
Price / share
$74.75
Trade value
$709.86K
% of position
15.2%
11/11/2020
62.53K→53.03K
Common Stock
Direct
Shares
−908.00
Price / share
$75.23
Trade value
$68.31K
% of position
1.7%
11/11/2020
53.03K→52.12K
Common Stock
Direct
Shares
−1.50K
Price / share
—
Trade value
—
% of position
2.9%
11/11/2020
52.12K→50.62K
Total
Net shares
−14.91K
Net value
-$999.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/11/2020 | S · Sale | −3K | $73.56 | $221.06K | 4.6% | 65.53K | 62.53K |
| Common Stock Direct | 11/11/2020 | S · Sale | −9.50K | $74.75 | $709.86K | 15.2% | 62.53K | 53.03K |
| Common Stock Direct | 11/11/2020 | S · Sale | −908.00 | $75.23 | $68.31K | 1.7% | 53.03K | 52.12K |
| Common Stock Direct | 11/11/2020 | G · Gift | −1.50K | — | — | 2.9% | 52.12K | 50.62K |
| Total | −14.91K | -$999.23K | ||||||
Derivative Transactions0
No derivative transactions reported